SynthesisJournal of global health2023

Nirmatrelvir plus ritonavir remains effective in vaccinated patients at risk of progression with COVID-19: A systematic review and meta-analysis.

Huamin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.